Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Where Will Ocugen Be in 1 Year?

TheMotleyFool

0 0

The past 18 months have been a roller coaster for Ocugen (NASDAQ: OCGN). Shares of the biotech company skyrocketed in early 2021 after it announced an agreement with India-based Bharat Biotech. The deal stipulated that Ocugen would hold the right to commercialize the Covaxin coronavirus vaccine, which was originally developed by Bharat Biotech, in the U.S. and Canada.

However, shares of Ocugen have now lost most of the gains they accumulated in 2021 due to various regulatory headwinds that delayed the launch of Covaxin. Ocugen, though, has yet to give up on this project, and with a little more time, the company may be able to turn things around. Will one year be enough for Ocugen to bounce back?

Image source: Getty Images.

Source Fool.com

Like: 0

OCGN

Share